|
Pharma cos to make big ticket investments as Gujarat FDCA approves layout designs of 185 drug units post GST
|
|
Shardul Nautiyal, Mumbai
November 20 , 2018
|
|
|
Around 306 pharmaceutical companies including the 185 companies which got layout design approvals from Gujarat Food and Drug Control Administration (FDCA) to set up plants are likely to start operations in Gujarat. Out of 306 companies, 121 are expanding their footprint in the state of Gujarat.
The state has witnessed a surge in interest from both foreign and domestic big players in commissioning plants of APIs, formulations and medical devices since July 2015 after the introduction of goods and services tax (GST).
In a major boost to the domestic pharmaceutical industry, a large number of pharmaceutical companies have got approvals for their plant layout designs which had to shut down their production facilities in the northern part of the country in the event of expiry of tax holidays granted during 2001-02.
Pune based Emcure Pharmaceuticals is ready to commission the facility at Sanand based on the plant design approvals. Japanese company Otsuka Pharmaceutical Company Ltd, MedTech companies like Abbott, Israel based Teva Pharmaceutical Industries Ltd and Baxter will set up facilities based on the approvals.
Other companies to follow suit are Punishka Healthcare Pvt Ltd, which is into injectables, will invest Rs. 300 crore for its plant in Ahmedabad among other major ones like Edkem Pharmaceuticals Pvt Ltd to start operations with an investment of Rs. 150 crore among others like Avantika Medex Pvt Ltd, Derek Healthcare, Dewcare Concept Pvt Ltd, Afeel Life Care, Rajkot and Moksh Pharmaceuticals Pvt Ltd, Vadodara.
It is also easier and timely for the pharma companies to start their operations smoothly without much hiccups as Gujarat government has revised its time line for grant of manufacturing licenses to 60 days from the earlier stipulated time line of 120 days.
Revision of timeliness for grant of manufacturing licenses has been a major initiative of the government as part of Pharma Vision 2020 under the Right of Citizens to Services for speedy issuance of licenses.
Gujarat government is also awaiting a favourable policy on bulk drugs and medical devices as the Centre is mulling over to frame an exclusive policy on the same.
|
|
|
|
|
|
|
|
TOPICS
|
That foods might provide therapeutic benefits is clearly not a new concept. ...
|
|
|
|
|